Activity of the adeno-associated virus P5 transcriptional control region was found to be induced by adenovirus EIA gene products. A pair of adjacent sequence elements was found to mediate both basal and ElA-induced P5 activity. The first element is a binding site for the major late transcription factor (MLTF), a factor first identified on the basis of its binding to a specific sequence within the adenovirus major late promoter. The second element is a tandemly repeated 10-base-pair sequence whose relationship to previously described binding sites is unclear. Each element individually conferred ElA responsiveness on a heterologous promoter, and deletion analysis demonstrated that each contributed to the level of P5 activity in the presence of EIA products both in transfection-and infection-based assays. Although deletion of the MLTF binding site led to reduced P5 transcriptional activity in the presence of EIA proteins, the deletion generated enhanced P5 basal activity in the absence of the transcriptional activator. The negative effect of the MLTF binding site in the absence of activator and its positive effect in the presence of activator combine to enhance the magnitude of the response by the P5 control region to EIA gene products. site (16, 37) suggests that they are produced by three separate promoters, designated P5, P19, and P40.
The human adeno-associated virus (AAV) type 2 is a defective parvovirus (for a review, see reference 3). The viral genome is a 4,681-nucleotide, single-stranded DNA (57) , including terminal repeats of 145 bases which serve as origins and primers for DNA replication (50, 53) . The viral DNA sequence contains two major open reading frames. The right half of the conventional AAV map encodes three viral structural (cap) proteins (5, 28, 48) , and the left half encodes four nonstructural (Rep) proteins (42) . Three sets of capped and polyadenylated AAV mRNAs have been identified (15, 17, 34, 39) . Their 5' ends are located at map positions 5, 19, and 40, respectively (16, 37) , and their 3' ends coterminate at map position 96 (57) . The presence of TATA boxes approximately 30 bases upstream from each RNA start site (16, 37) suggests that they are produced by three separate promoters, designated P5, P19, and P40.
Although AAV can replicate under appropriate conditions in the absence of a helper virus (60) , efficient replication requires coinfection with adenovirus or herpesvirus (3) . One of the helper functions provided by adenovirus is the transactivating activity of the early region 1A (ElA) gene products (26, 33, 47, 58) . The ElA gene is the first gene expressed during an adenovirus infection, and its gene products can transcriptionally activate other adenovirus early genes (for reviews, see references 2 and 43). In addition, ElA products have been shown to activate transcription of the AAV P19 promoter (58) .
Here we report that the AAV P5 promoter can be induced by adenovirus ElA gene products. Deletion analysis identified two sequence elements that mediate transcriptional activity of the control region. The first element is a binding site for the adenovirus major late transcription factor (MLTF). It rendered a heterologous promoter modestly inducible by ElA gene products. This element reduced the basal activity and enhanced the ElA-induced activity of the P5 control region. The second element is a tandemly re-* Corresponding author. peated 10-base-pair (bp) sequence. This sequence rendered a heterologous promoter ElA responsive and enhanced the ElA-induced activity of the P5 promoter. The two elements appear to interact to make the P5 promoter highly responsive to ElA gene products.
MATERIALS AND METHODS
Plasmids, viruses, and cells. A DNA segment including the AAV P5 transcriptional control region (nucleotide numbers 190 to 310; XbaI-HhaI cleavage product) was subcloned from psub201 (49) and then fused with the chloramphenicol acetyltransferase (CAT) expression vector (12) to generate the pAAVP5-CAT190 plasmid (see Fig. 1 ). Deleted derivatives of the P5 promoter were constructed by using Bal3l nuclease (38) , and deletion endpoints were mapped by DNA sequencing (51) . Several deletion derivatives were prepared in which the rabbit ,-globin cDNA from pSV2-p-globin (56) was substituted for the CAT coding region. To construct plasmids for generation of AAV/P5-CAT transducing viruses, the P5-CAT-specific DNA segment was excised from several pAAVP5-CAT plasmids and ligated to the small XbaI fragment from the AAV recombinant plasmid psiib2ol(+) (49) . These recombinant virus plasmids contain the P5-CAT sequences inserted between the two cis-acting terminal repeats of AAV.
The pElA-ElB plasmid containing the entire adenovirus type 5 (AdS) El region (nucleotide numbers 1 through 5778), pElA containing only the ElA region (nucleotide numbers 1 through 1767), and pElB containing only the E1B region (nucleotide numbers 1339 through 5778) have been described previously (21, 46 plasmid to generate the pBC19-8, pBC19-12, and pBC21-24 plasmids (see Fig. 6 ). Sequencing data indicated that pBC19-12 contains the repeat inserted 5' of the SV40 promoter and in the same orientation as that in the P5 promoter, pBC19-8 contains the repeat inserted in the opposite orientation, and pBC21-24 contains the repeat inserted in the 3' end of the SV-CAT expression cassette. Similarly, a 16-bp synthetic DNA containing the MLTF binding site homology (-70 to -85 with respect to the AAV transcription start site) was inserted into the StnaI site of the pBC19 or pBC21 plasmid to generate the pBC19-6, pBC19-11, pBC21-30, and pBC21-31 plasmids. Sequencing data indicated that pBC19-6 and pBC19-11 contain the MLTF binding site homology inserted in opposite orientations upstream of the TATA motif of the SV40 early promoter and pBC21-30 and pBC21-31 contain the MLTF binding site homology inserted in opposite orientations in the 3' end of the SV-CAT expression cassette.
AAV/P5-CAT recombinant virus stocks were prepared by cotransfecting 2 jg of pSM620 DNA (wild-type AAV [50] )
into HeLa cells by the DEAE-dextran method (40) [19] ) with Baml-HI, separation of the resulting fragments by electrophoresis, and transfer of the entire pattern to nitrocellulose strips. After hybridization, the radioactivity in individual bands was quantified by scintillation counting. Measurement of DNA stability. Analysis of plasmid DNA stability was conducted as described by Alwine (1) . Briefly, at 48 h after transfection, low-molecular-weight DNA was prepared (24) , equivalent portions of each sample were digested with XhbI, subjected to electrophoresis in a 1% agarose gel, and hybridized to a 32P-labeled P3-globin-specific probe DNA (55) . After autoradiography, bands were quantified by densitometric scanning.
Band-shift, footprint and photo-cross-link analysis. Two oligodeoxynucleotides containing MLTF binding sites were prepared and used in these experiments. One contained the sequence of the MLTF binding site present on the Ad2 chromosome (5'-GGTGTAGGCCACGTGACCGGGTGTT C-3'), and the other contained the homologous sequence present in the AAV P5 promoter (5'-GAGGTCACGTGAGT GT-3').
MLTF activity was partially purified from a nuclear extract of HeLa cells (9) by chromatography on a TSK phenyl-5PW matrix in an LKB UltroPac HPLC column (Pharmacia LKB Biotechnology, Inc., Piscataway, N.J.). Activity was localized in the elution profile by band-shift assay, using the 32P-labeled oligodeoxynucleotides corresponding to the adenovirus and P5 MLTF binding sites. The peak fraction was used as the source of MLTF for footprint, band-shift, and photo-cross-linking analysis.
Band-shift assays (10) were pertormed as described previously (20) , with minor modifications. Each reaction mixture contained 2 pd of partially purified MLTF, 10 fmol of 32P-labeled probe DNA, and 2 Vig of poly(dI) poly(dC).
Binding mixtures were incubated at 25°C for 30 min, DNAprotein complexes were separated from free DNA by electrophoresis in a 4(4 polyacrylamide gel (bisacrylamide-acrylamide, 1:20) , and gels were transferred to 3MM paper, dried, and then exposed to film.
Footprint analysis (11) utilized a DNA substrate comprising the sequence between -96 to +24 relative to the P5 transcriptional start site. The substrate DNA was 32P-labeled at the end at position -96 by filling in the overhanging end of an XhbI cleavage site with the Klenow fragment of DNA polymerase I and [a-32P]dCTP. DNA-protein complexes were formed as described above for band-shift assays and treated with 10 pg of DNase I per ml for 1 min at 25°C; DNA was purified and then analyzed for protected regions by electrophoresis in a 6% polyacrylamide gel containing 8 M urea.
To photo-cross-link the MLTF to its binding site, reaction mixtures were prepared as described above for band-shift assays and incubated to allow binding to reach equilibrium. Reaction mixtures were pipetted onto parafilm and irradiated for various times at a distance of 4.5 cm from a UV lamp " HeLa cells were cotransf'ected with pAAVP5-)3G190 plus either pBR322 W or pElA-EIB, and nuiclei were prepared 48 h latter. Run-on transcription was performed in the presence of [os-32P]UTP and nuclear RNA was prepaired and hybridized to 3-globin and aictin (non-ElA-indLucible) probe DNAs which were immobilized on nitrocellulose filter patper. After filters were washed, radioactivity was quantified.
b Induiction ratios were calculated, normalizing the radioactivity hybridized to actin DNA in the presence and aibsence of EIA products to reflect the flct * 9 9 * that EIA products do not inflLtence actin transcription r-ates. (310-nm filter; Fotodyne Inc., New Berlin, Wis.). Samples were not treated with nuclease since the substrate DNA was labeled at its 5' ends. Cross-linked complexes were analyzed by electrophoresis in an 12.5% polyacrylamide gel containing 0.1% sodium dodecyl sulfate. After electrophoresis, the gel was dried onto filter paper, and radioactive bands were visualized by autoradiography.
RESULTS
Induction of the AAV P5 control region by adenovirus ElA products. pAAVP5-CAT190 was constructed to assay the effect of adenovirus ElA gene products on the activity of the AAV P5 transcriptional control region. This plasmid contains the AAV P5 5'-flanking domain (Fig. 1A) (Fig. 1C , + pElA-EIB) were included in the transfection mixture with pAAVP5-CAT190, the level of CAT activity increased by a factor of 7 and 23, respectively. The adenovirus ElB gene alone did not stimulate pAAVP5-CAT190 expression above basal levels (data not shown). Nevertheless, pElA-EIB was consistently observed to be a more potent inducer of AAV P5-controlled CAT expression, presumably because the E1B coding region contains a (cis-acting element that enhances ElA expression (27) . CAT expression was also stimulated if ElA function was provided by adenovirus infection of pAAVP5-CAT190-transfected HeLa cells (Fig. 1C, + AdS) .
In multiple experiments, pAAVP5-CAT190 expression was induced by a factor of 40 + 15.1 in the presence of pE1A-ElB. This level of induction was equal to or somewhat greater than that obtained for the well-studied adenovirus E2 early promoter (pE2A-CAT, 29 + 14-fold induction) and much greater than that obtained for the ElA control region (pElA-CAT, 2.9 + 1.1-fold induction).
A transcriptional rate analysis was performed to directly demonstrate that EIA gene products could stimulate transcriptional activity of the AAV P5 control region (Table 1) . HeLa cells were cotransfected with either pAAVP5-,3G190 (identical to pAAVP5-CAT190 except that the 3-globin codinQ region is substituted for the CAT sequence since CAT-encoding mRNAs were found to be unstable) plus pBR322 (included to control for DNA concentration in the transfecting mixture) or pAAVP5-3G190 plus pElA-ElB. In vitro transcriptional run-on analysis demonstrated that transcription of P3-globin sequences was stimulated by a factor of 11 When ElA gene products were present.
To be certain this result reflected induction of AAV P5-directed transcriptional initiation, two control experiments were performed. First, an experiment was conducted to confirm that the transcriptional induction resulted from initiation at the AAV P5 start site ( Fig. 2A) . RNA was prepared at 48 h after cotransfection of HeLa cells with pAAVP5-3G190 and pBR322 or pElA-EIB, and 3-globin transcripts initiated at the AAV P5 start site were assayed by RNase protection analysis. There was a 15-fold increase in the level of appropriately initiated 3-globin RNA when pAAVP5-3G190 was cotransfected with the ElA-expressing plasmid. A faster-migrating protected fragment was also observed in this analysis, and its origin is uncertain. Shortened 3-globin transcripts have been observed previously (44, 56) , and they may be due to initiation downstream of the major start site. The shortened fragment was also induced by ElA gene products. In the second control experiment, the stability of pAAVP5-3G190 DNA was assayed subsequent to cotransfection in the presence of pBR322 compared with pElA-EIB DNA (Fig. 2B) . Low-molecular-weight DNA was prepared from the same experiment in which steadystate P-globin RNA levels were analyzed above. pAAVP5-3G190 DNA levels were assayed by DNA blot analysis, Vot-63. 1989 on In sum, pAAVP5-,BG190 DNA is not markedly stabilized in HeLa cells expressing pElA-EIB-coded products, and the 3-globin RNA molecules encoded by pAAVP5-3G190 are initiated at the AAV P5 start site. Therefore, we can conclude, on the basis of the enhanced rate of ,B-globin transcription in the presence of pElA-ElB, that the AAV P5 control region is stimulated by ElA gene products.
AAV P5 sequence elements that respond to adenovirus EIA products. In addition to a TATA motif, the AAV P5 5'-flanking region contains two additional sequence elements that stand out on initial inspection (Fig. 1A) To evaluate the role of these and other sequence elements in the function of the AAV P5 control region, a series of unidirectional deletion mutations was constructed within the P5 segment of pAAVP5-CAT190 (Fig. 3A) . Basal and E1A-induced activity of each mutant AAV P5 control region was then evaluated by CAT assay of transfected HeLa cell extracts. The experiment was repeated three times, and a representative trial is displayed in Fig. 3B . Basal activity remained low and constant for all mutant plasmids with the exception of pAAVP5-CAT216 (unidirectional deletion extends from upstream to position -216, Fig. 3B ). This variant Extracts were prepared at various times after HeLa cells were infected (hr p.i.) with recombinant AAV viruses, and CAT activity was determined. Assays were performed either in the absence (-) or presence (+) of coinfecting adenovirus to provide ElA function. Percent conversion was determined by measuring the radioactivity in acetylated versus unacetylated spots.
exhibited enhanced (about threefold) CAT expression in the absence of ElA products. In contrast, it exhibited a reduced (about threefold) level of ElA-induced activity compared with that of plasmids that contained the sequence interval between 190 to 216. As a result, pAAVP5-CAT216 exhibited a substantially reduced EIA induction ratio (CAT activity in the presence divided by activity in the absence of EIA products). The behavior of pAAVP5-CAT216 suggests there may be a sequence between position 190 to 227 that negatively influences basal activity but positively contributes to ElA-induced activity of the AAV P5 control region. The MLTF binding site homology is located within this interval. ElA-inducible activity was completely lost when the deletion was extended to sequence position 243. pAAVP5-CAT243 displays identical basal and induced levels of CAT activity. Thus, the interval between position 216 to 243 appears to contain a sequence element that responds positively to the presence of ElA products. This interval contains the R1-R2 repeat.
Two recombinant AAV viruses were produced to confirm that the response of P5 elements to EIA products measured in transfection assays properly reflected their role in AAVinfected cells. pAAVP5-CAT190 and pAAVP5-CAT243 were used to generate derivatives of psub201, an infectious clone of AAV (49) . DNA segments containing the P5 transcriptional control region plus CAT reporter gene were substituted for the AAV coding region between the viral terminal repeat sequences (Fig. 4A) . Recombinant viruses were propagated by using pSM620 (recombinant clone of wild-type AAV [50] ) as a helper DNA. The same amount of the AAV/P5-CAT recombinant viruses was used to infect HeLa cells either alone or in the presence of adenovirus. AAVP5-CAT190 virus generated substantial CAT activity in cells coinfected with adenovirus, whereas AAVP5-CAT243 generated a much reduced signal under similar conditions (Fig. 4B) . The level of CAT activity observed in this experiment for AAVP5-CAT243 subsequent to coinfection with the AAV variant, wild-type AAV, and adenovirus (Fig. 4B) was substantially greater than background levels of CAT activity generated after transfection with pAAVP5-CAT243 plus pElA-ElB (Fig. 3B) . This difference is due to the fact that AAVP5-CAT243 DNA has replicated, greatly amplifying the CAT template copy number.
The domain of the P5 transcriptional control region located within sequence position 190 to 243 clearly plays a key role in P5 activity within AAV-infected cells.
MLTF binding site and R1-R2 repeat can each confer ElA-inducibility on a heterologous promoter. The roles of the R1-R2 repeat and the MLTF binding site homology in the response of the AAV P5 promoter to ElA products were further investigated by placing them upstream of a heterologous promoter that was not ElA responsive. The two elements were separately inserted into plasmids containing a CAT reporter gene controlled by the SV40 early promoter (TATA motif plus start site) and tested for the ability to respond to EIA products in HeLa cells transfected with test plasmids plus pElA-E1B ( Table 2) .
As expected, expression of the parental plasmids, pBC19 and pBC21, was not induced by ElA products since they contained a TATA motif previously shown to be nonresponsive (54) . pBC19-8 and pBC19-12 contained the R1-R2 element on a 22-bp segment (5'-GTTTTGCGACATTTTGCGA CAC-3') inserted on the 5' side of the CAT sequence in opposite orientations. The inserts did not increase basal b The test element was inserted into pBC19 or pBC21 in the same (+) or the opposite (-) orientation relative to the transcriptional start site as it is found in the AAV P5 control region.
' The percent conversion of CAT (0.12%) by extracts of cells transfected with a plasmid that did not contain a CAT coding region was subtracted from all experimental values.
" Induction was calculated as the percent conversion of CAT obtained when indicated plasmids were cotransfected with pElA-ElB DNA divided by the percent conversion of CAT when they were cotransfected with pBR322 DNA.
" ML, MLTF binding site.
CAT expression, but did increase the level of expression in the presence of ElA products. Expression from pBC19-8 and pBC19-12 was induced by factors of 3 and 8, respectively. pBC21-24 contained the R1-R2 repeat at the 3' side of the CAT coding region, and it exhibited a marginal, 1.7-fold, induction in the presence of ElA products.
The response of pBC19-8 and pBC19-12 to ElA products was further studied by transfection of 293 cells which constitutively express ElA gene products (Table 3) . Both R1-R2-containing plasmids generated about 20-fold more CAT activity than the parental plasmid that lacked the sequence. The orientation of the R1-R2 insert upstream of the SV40 TATA motif reproducibly (three independent experiments) influenced the magnitude of the response to ElA products in the HeLa cell cotransfection assay ( Table 2) but not that in the 293 cell assay (Table 3 ). The reason for the " The test element was inserted into pBC19 or pBC21 in the same (+) or the opposite (-) orientation relative to the transcriptional start site as it is found in the AAV P5 control region.
' Induction was calculated as the percent conversion of CAT obtained for indicated test plasmids divided by the percent conversion of CAT obtained for pBC19.
assay-dependent difference is not clear. Possibly it reflects a higher level of ElA protein in 293 cells than in transfected HeLa cells. This could result in more efficient trans-activation in 293 cell assays (4) .
pBC19-6 and pBC19-11 contain the MLTF binding site homology on a 16-bp segment (5'-GAGGTCACGTG AGTGT-3') inserted in opposite orientations upstream of the TATA motif of the SV40 early promoter. These plasmids displayed the same basal level CAT activity as the parental plasmid but were induced by a factor of 2 to 4 in response to ElA products when assayed in HeLa cells by cotransfection with pElA-ElB (Table 2 ) or in 293 cells (Table 3 ). The level of their response to EIA compared favorably with that seen for pMLP-CAT which contains the entire major late transcriptional control region ( Table 2 ). Plasmids containing this sequence inserted to the 3' side of the CAT sequence, pBC21-30 and pBC21-31, were not responsive to ElA gene products ( Table 2) .
In sum, both the MLTF binding site homology and the R1-R2 sequence endowed EIA responsiveness on a heterologous promoter. Both sequence elements presumably contributed to the overall response of the PS promoter to ElA gene products. The R1-R2 sequences displayed the greater response to the adenovirus trans activator. The magnitude of the induction mediated by R1-R2 depended on the orientation of the sequence and the assay employed.
MLTF binds to the MLTF binding site homology in AAV P5. Although the P5 control region contained a sequence that closely resembled a bona fide MLTF recognition site, it was necessary to prove that the factor did, indeed, bind to the sequence. Accordingly, MLTF activity was partially purified from a nuclear extract on a TSK phenyl-5PW matrix, and its interactions with the P5 homology were analyzed.
Footprint analysis (11) was performed by using the partially purified MLTF activity and a P5-specific DNA fragment as substrate (Fig. 5) Fig. 1A) . Thus, the footprint analysis is consistent with the possibility that MLTF binds to the AAV PS promoter.
Next, band-shift analysis (10) was utilized to test the ability of the PS and adenovirus MLTF binding sites to cross-compete for factor binding (Fig. 6) . Two doublestranded oligodeoxynucleotides were chemically synthesized that corresponded to the bona fide adenovirus MLTF binding site and the PS homology. When either of the oligodeoxynucleotides was 32P-labeled at its 5' ends and used as a substrate in a DNA band-shift assay employing partially purified MLTF, two characteristic shifted bands were evident. The bands produced by using either of the two DNA substrates migrated identically. The generation of the shifted bands could be inhibited either by self competition, in which an excess of unlabeled homologous oligodeoxynucleotide was included in the binding mixture, or by competition with the heterologous DNA. Although the adenovirus-specific oligodeoxynucleotide appears to be a stronger crosscompetitor than PS DNA in the experiment displayed in Fig.  6 Finally, cross-linking with UV light (8) was employed to examine the size of the polypeptide that bound to the P5 homology (Fig. 7) . The 32P-labeled oligodeoxynucleotide containing the P5-specific sequence was mixed with partially purified MLTF, binding was allowed to reach equilibriuIM. the mixture was subjected to UV irradiation for various times, and the cross-linked material was analyzed by electrophoresis. A band migrating at about 46 kilodaltons (kDa), the reported size of MLTF (43 to 48 kDa [8, 52] binding site and a direct repeat termed R1-R2 (Fig. 3 , Tables  2 and 3). A variety of observations support the conclusion that the MLTF binds to the P5 control region. First, in a DNase I protection assay, a partially purified preparation of MLTF protected a 16-nucleotide stretch that included the MLTF binding site homology in P5 (Fig. 5) . Second, specific shifted complexes formed by using oligodeoxynucleotides containing either the bona fide adenovirus MLTF binding site or the P5 homology migrated identically, and the two DNAs exhibited cross-competition for the factor (Fig. 6) . Third, photo-cross-linking and analysis of the resulting complex by electrophoresis demonstrated that the P5-specific oligodeoxynucleotide bound to a polypeptide of about 46 kDa, the reported size of the MLTF (8. 52) , and inclusion of an excess of unlabeled oligodeoxynucleotide containing the adenovirus MLTF binding site in the binding mixture could prevent cross-linking to the P5 DNA (Fig. 7) .
Besides its role in adenovirus major late and AAV P5 transcription, the MLTF has been shown to bind and activate both the mouse metallothionein I (6) and the rat y-fibrinogen transcriptional control regions (7) . Inspection of the four binding sites indicates they share an invariant 6-bp core sequence, CNCGTGA. The core region of the AAV P5 sequence is palindromic, TCACGTGA.
The second P5 sequence element that is involved in ElA-mediated induction comprises a direct repeat, R1-R2, each copy of which is 10 bp in length. (Tables 2 and 3 ). The MLTF binding site, when appended to the SV40 early start site plus TATA motif (neither the SV40 TATTTAT nor the AAV P5 TATTTA sequences would be predicted to be ElA responsive [54] ), generated a control region that was modestly responsive to EIA products (two-to fourfold). Insertion of the R1-R2 sequence generated a more substantial 3-to 20-fold increase in the same assays. It appears very likely that the R1-R2 element binds a cellular factor whose activity can be directly or indirectly modulated by the adenovirus ElA gene products.
The MLTF binding site and the R1-R2 element both contribute to the activity of the P5 promoter in the presence of ElA products. Deletion of the MLTF binding site reduced P5 activity by a factor of about 3 (Fig. 3B, pAAVP5-CAT216) , and simultaneous deletion of the R1-R2 repeat further reduced P5 activity by a factor of about 25 (Fig. 3B,  pAAVP5-CAT243 ). Deletion of both elements generated P5 derivatives with very low basal activity which did not respond to ElA products.
In addition to its effect on induced expression, deletion of the MLTF binding site alone reproducibly led to an approximately threefold increase in the basal activity of the P5 promoter (Fig. 3B, pAAVP5-CAT216) . Apparently, the MLTF binding site leads to a reduction in uninduced basal activity of P5. The MLTF is believed to enhance the basal activity of other control regions that contain its binding site (discussed in references 7 and 36). although it did not do so when inserted upstream of the SV40 TATA motif in pBC19-6 and pBC19-11 ( Table 2 ). The negative effect of the MLTF binding site on basal P5 expression likely derives from the context in which it resides within the PS promoter. Perhaps the MLTF and the factor that binds the R1-R2 element interfere with each other's binding or activity in the absence of EIA products. The trans-activating proteins could then stimulate the P5 promoter by directly or indirectly altering one or both of the factors so that they no longer interfere but cooperate to induce transcription.
It is clear that the combination of the MLTF binding site and R1-R2 repeats influences both basal and induced P5 activity. The close apposition of the two binding sites has apparently generated a transcriptional control region that displays a greater induction in response to EIA products than either site alone could generate. This has been achieved by combining an inhibitory effect on basal activity with stimulatory effects achieved in the presence of adenovirus ElA gene products.
